{
    "SPADE_N_05876": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_05876",
            "Peptide Name": "Ranatuerin-2Pb (Frogs, amphibians, animals)",
            "Source": "Lithobates pipiens (Northern leopard frog) (Rana pipiens)",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGCRT",
            "Sequence Length": 34,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/A0A513ZTP5"
            ],
            "Protein Existence": "Transcript level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal"
            ],
            "Target Organism": "[Ref.31242693] Gram-positive bacteria:Staphylococcus aureus (MIC=8 μM; MBC=8 μM), MRSA (MIC=16 μM; MBC=32 μM), Enterococcus faecalis (MIC>256 μM; MBC>256 μM);Gram-negative bacteria:Escherichia coli (MIC=8 μM; MBC=8 μM), Pseudomonas aeruginosa (MIC>256 μM; MBC>256 μM);Fungi:Candida albicans (MIC=8 μM; MBC=16 μM)",
            "Hemolytic Activity": "[Ref.31242693] 7% hemolysis at 2 μM, 23% hemolysis at 8 μM, 50% hemolysis at 16 μM, 71% hemolysis at 32 μM, 100% hemolysis at 64 μM on horse erythrocytes.",
            "Cytotoxicity": "[Ref.31242693] The IC50 values which represents the inhibitory effect of Ranatuerin-2Pb on the proliferation of NCI-H157, MCF-7, U251MG and PC-3 are 1.453 μM, 7.254 μM, 2.172 μM and 2.251 μM. In addtion, Ranatuerin-2Pb showed no inhibitory effect on the proliferation of MDA-MB-435s.  DETAILED DATA:①The cell viabillity of NCI-H157 induced by Ranatuerin-2Pb is 96.2%, 96.9%, 85.6%, 60%, 5% and 4.4% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 95%, 89.4%, 41.2%, 16.2% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ②The cell viability of MCF-7 induced by Ranatuerin-2Pb is 100.6%, 92.5%, 90%, 99.4%, 36.2% and 11.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 100%, 98.1%, 92.5%, 7.5%, 8.7% and 8.7% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ③The cell viability of U251-MG induced by Ranatuerin-2Pb is 100%, 105.6%, 108.1%, 102.5%, 59.4% and 17.5% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 99.4%, 99.4%, 75.6%, 18.7%, 11.9% and 18.1% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ④The cell viability of PC-3 induced by Ranatuerin-2Pb is 108.7%, 112.5%, 84.4%, 80.6%, 28.1% and 16.2% at peptide concentrations of 0.001, 0.01, 0.1, 1, 10, 100 μM, while the cell viability induced by Melittin is 110%, 113.1%, 109.4%, 33.1%, 16.9% and 16.2% at 0.001, 0.01, 0.1, 1, 10, 100 μM. ⑤ The cell viability of MDA-MB-435S induced by Ranatuerin-2Pb is 96.9%, 88.8%, 96.9%, 88.1%, 100 and 25.6%, while the cell viability induced by Melittin is 100%, 93.1%, 82.5%, 18.8%, 18.8% and 18.1%.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Ranatuerin-2Pb might also possess two helical segments at respective N-terminus and C-terminus, and the last two residues are probably included in the helix domain.",
            "Formula": "C155H272N42O46S2",
            "Mass": 3524.2,
            "PI": 9.7,
            "Net Charge": 4,
            "Hydrophobicity": 0.59,
            "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria. Antifungal activity against Candida albicans.",
            "Literature": [
                {
                    "Title": "Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues",
                    "Pubmed ID": "31242693",
                    "Reference": "Biomolecules. 2019 Jun 25;9(6)249. doi 10.3390/biom9060249.",
                    "Author": "Zhou, XW; Shi, DN; Zhong, RM; Ye, ZM; Ma, CB; Zhou, M; Xi, XP; Wang, L; Chen, TB; Kwok, HF",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31242693"
                }
            ],
            "Frequent Amino Acids": "TKL",
            "Absent Amino Acids": "EHMOPQUWY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 14,
            "Polar Residues": 23,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_12064",
                    "Similarity": 1.0,
                    "Sequence": "SFLTTVKKLVTNLAALAGTVIDTIKCKVTGGC"
                },
                {
                    "SPADE_ID": "SPADE_UN_12065",
                    "Similarity": 1.0,
                    "Sequence": "SFLTTVKKLVTNLAAL"
                },
                {
                    "SPADE_ID": "SPADE_UN_00154",
                    "Similarity": 0.9411764705882353,
                    "Sequence": "SFLTTVKKLVTNVAALAGTVIDTIKCKITGGCRT"
                }
            ]
        }
    }
}